1
Kroenke, K, Spitzer, RL, Williams, JB, Monahan, PO, Lowe, B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med
2007; 146: 317–25.
2
Wittchen, HU. Generalized anxiety disorder: prevalence, burden, and cost to society. Depress Anxiety
2002; 16: 162–71.
3
Simon, GE, VonKorff, M. Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area study. Am J Psychiatry
1991; 148: 1494–500.
4
Stein, MB, Sherbourne, CD, Craske, MG, Means-Christensen, A, Bystritsky, A, Katon, W, et al. Quality of care for primary care patients with anxiety disorders. Am J Psychiatry
2004; 161: 2230–7.
5
Konnopka, A, Leichsenring, F, Leibing, E, König, HH. Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: a systematic review. J Affect Disord
2009; 114: 4–31.
6
Katon, W. Panic disorder: relationship to high medical utilization, unexplained physical symptoms, and medical costs. J Clin Psychiatry
1996; 57 (suppl 10): s11–8.
7
Kolbasovsky, A, Reich, L, Futterman, R, Meyerkopf, N. Reducing the number of emergency department visits and costs associated with anxiety: a randomized controlled study. Am J Manag Care
2007; 13: 95–102.
8
Beesdo, K, Krause, P, Höfler, M, Wittchen, HU. Do primary care physicians know generalized anxiety disorders? Estimations of prevalence, attitudes and interventions (in German). Fortschr Med Orig
2001; 119 (suppl 1): s13–6.
9
Roy-Byrne, PP, Stein, MB, Russo, J, Mercier, E, Thomas, R, McQuaid, J, et al. Panic disorder in the primary care setting: comorbidity, disability, service utilization, and treatment. J Clin Psychiatry
1999; 60: 492–9.
10
Wittchen, HU, Hoyer, J, Höfler, M, Krause, P. Family physician's interventions and prescribing practice. Results of the GAD-P study (in German). Fortschr Med Orig
2001; 119 (suppl 1): s36–41.
11
Katon, W, Russo, J, Sherbourne, C, Stein, MB, Craske, M, Fan, MY, et al. Incremental cost-effectiveness of a collaborative care intervention for panic disorder. Psychol Med
2006; 36: 353–63.
12
Katon, WJ, Roy-Byrne, PP, Russo, J, Cowley, D. Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder. Arch Gen Psychiatry
2002; 59: 1098–104.
13
Marinopoulos, SS, Dorman, T, Ratanawongsa, N, Wilson, LM, Ashar, BH, Magaziner, JL, et al. Effectiveness of continuing medical education. Evid Rep Technol Assess
2007; 149: 1–69.
14
Löwe, B, Spitzer, RL, Zipfel, S, Herzog, W. Gesundheitsfragebogen für Patienten (PHQ-D). Komplettversion und Kurzform. Testmappe mit Manual, Fragebögen, Schablonen [Patient Health Questionnaire (PHQ–D): Complete Version and Short Version. Manual, Questionnaires and Templates]. Pfizer, 2002.
15
Spitzer, RL, Kroenke, K, Williams, JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA
1999; 282: 1737–44.
16
Campbell, MK, Elbourne, DR, Altman, DG. CONSORT statement: extension to cluster randomised trials. BMJ
2004; 328: 702–8.
18
Canadian Psychiatric Association. Clinical practice guidelines. Management of anxiety disorders. Can J Psychiatry
2006; 51 (suppl 2): s7–92.
19
Dengler, W, Selbmann, HK. Leitlinien zu Diagnostik und Therapie von Angsterkrankungen; Praxisleitlinien in Psychiatrie und Psychotherapie (Bd. 2) . Steinkopf, 2000.
20
Laidley, TL, Braddock, CH III. Role of adult learning theory in evaluating and designing strategies for teaching residents in ambulatory settings. Adv Health Sci Educ Theory Pract
2000; 5: 43–54.
21
Wittmund, B, Wilms, HU, Bull, N, Angermeyer, MC. Collaboration of a specialised outpatient clinic with office-based general practitioners and psychiatrists in the treatment of anxiety disorders (in German). Verhaltenstherapie
2003; 13: 284–90.
22
World Health Organization (WHO). The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO, 1992.
23
Löwe, B, Gräfe, K, Zipfel, S, Spitzer, RL, Herrmann-Lingen, C, Witte, S, et al. Detecting panic disorder in medical and psychosomatic outpatients: comparative validation of the Hospital Anxiety and Depression Scale, the Patient Health Questionnaire, a screening question, and physicians' diagnosis. J Psychosom Res
2003; 55: 515–9.
24
Beck, AT, Epstein, N, Brown, G, Steer, RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol
1988; 56: 893–7.
25
Beck, AT, Steer, RA, Ball, R, Ranieri, W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess
1996; 67: 588–97.
26
EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy
1990; 16: 199–208.
27
Dolan, P. Modeling valuations for EuroQol health states. Med Care
1997; 35: 1095–108.
28
Sapin, C, Fantino, B, Nowicki, ML, Kind, P. Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health Qual Life Outcomes
2004; 2: 20.
29
Luppa, M, Heinrich, S, Matschinger, H, Sandholzer, H, Angermeyer, MC, König, HH, et al. Direct costs associated with depression in old age in Germany. J Affect Disord
2008; 105: 195–204.
30
Heinrich, S, Luppa, M, Matschinger, H, Angermeyer, MC, Riedel-Heller, SG, König, HH. Service utilization and health-care costs in the advanced elderly. Value Health
2008; 11: 611–20.
31
Roick, C, Kilian, R, Matschinger, H, Bernert, S, Mory, C, Angermeyer, MC. German adaptation of the client sociodemographic and service receipt inventory – an instrument for the cost of mental health care (in German). Psychiatr Prax
2001; 28 (suppl 2): s84–90.
32
Graf von der Schulenburg, JM, Greiner, W, Jost, F, Klusen, N, Kubin, M, Leidl, R, et al. German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus. Value Health
2008; 11: 539–44.
34
Krauth, C, Hessel, F, Hansmeier, T, Wasem, J, Seitz, R, Schweikert, B. Empirical standard costs for health economic evaluation in Germany – a proposal by the working group methods in health economic evaluation (in German). Gesundheitswesen
2005; 67: 736–46.
35
Rote Liste Service GmbH. Rote Liste 2006. Arzneimittelverzeichnis für Deutschland [Red List 2006. Directory of Pharmaceuticals for Germany]. Rote Liste Service GmbH, 2006.
36
Drummond, MF, Sculpher, MJ, Torrance, GW, O'Brien, B, Stoddart, GL. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, 2005.
37
Erickson, DH, Janeck, AS, Tallman, K. A cognitive-behavioral group for patients with various anxiety disorders. Psychiatr Serv
2007; 58: 1205–11.
38
Campbell, MK, Mollison, J, Grimshaw, JM. Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size. Stat Med
2001; 20: 391–9.
39
Campbell, M, Grimshaw, J, Steen, N. Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group. J Health Serv Res Policy
2000; 5: 12–6.
40
Glick, H, Doshi, J, Sonnad, SS, Polsky, D. Economic Evaluation in Clinical Trials. Oxford University Press, 2007.
41
Briggs, AH, O'Brien, BJ, Blackhouse, G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annu Rev Public Health
2002; 23: 377–401.
42
Greiner, W, Claes, C, Busschbach, JJ, Graf von der Schulenburg, JM. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ
2005; 6: 124–30.
43
Hirth, RA, Chernew, ME, Miller, E, Fendrick, AM, Weissert, WG. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making
2000; 20: 332–42.
44
King, M, Davidson, O, Taylor, F, Haines, A, Sharp, D, Turner, R. Effectiveness of teaching general practitioners skills in brief cognitive behaviour therapy to treat patients with depression: randomised controlled trial. BMJ
2002; 324: 947–50.
45
Downs, M, Turner, S, Bryans, M, Wilcock, J, Keady, J, Levin, E, et al. Effectiveness of educational interventions in improving detection and management of dementia in primary care: cluster randomised controlled study. BMJ
2006; 332: 692–6.
46
Morriss, R, Dowrick, C, Salmon, P, Peters, S, Dunn, G, Rogers, A, et al. Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms. Br J Psychiatry
2007; 191: 536–42.
47
Robinson, P, Katon, W, Von Korff, M, Bush, T, Simon, G, Lin, E, et al. The education of depressed primary care patients: what do patients think of interactive booklets and a video?
J Fam Pract
1997; 44: 562–71.
48
Gray, JAM. Evidence-Based Healthcare. How to Make Health Policy and Managment Decisions. Churchill Livingstone, 1997.
49
Fydrich, T, Dowdall, D, Chambless, DL. Reliability and validity of the Beck Anxiety Inventory. J Anxiety Disord
1992; 6: 55–61.
50
Harel, O, Zhou, XH. Multiple imputation: review of theory, implementation and software. Stat Med
2007; 26: 3057–77.
51
Tang, L, Song, J, Belin, TR, Unutzer, J. A comparison of imputation methods in a longitudinal randomized clinical trial. Stat Med
2005; 24: 2111–28.
52
Andlin-Sobocki, P, Wittchen, HU. Cost of anxiety disorders in Europe. Eur J Neurol
2005; 12 (suppl 1): s39–44.
53
Johnston, K, Buxton, MJ, Jones, DR, Fitzpatrick, R. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess
1999; 3: 1–76.
54
Gold, M, Siegel, J, Russel, L, Weinstein, M. Cost-Effectiveness in Health and Medicine. Oxford University Press, 1996.
55
Rasanen, P, Roine, E, Sintonen, H, Semberg-Konttinen, V, Ryynanen, OP, Roine, R. Use of quality-adjusted life years for the estimation of effectiveness of health care: a systematic literature review. Int J Technol Assess Health Care
2006; 22: 235–41.
56
König, HH, Roick, C, Angermeyer, MC. Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders. Eur Psychiatry
2007; 22: 177–87.
Cost-effectiveness of a primary care model for anxiety disorders
eLetters
No eLetters have been published for this article.